CA2412864A1 - Methodes de preparation et utilisation, et formulations pharmaceutiques renfermant 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one et leurs 17-esters - Google Patents

Methodes de preparation et utilisation, et formulations pharmaceutiques renfermant 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one et leurs 17-esters Download PDF

Info

Publication number
CA2412864A1
CA2412864A1 CA002412864A CA2412864A CA2412864A1 CA 2412864 A1 CA2412864 A1 CA 2412864A1 CA 002412864 A CA002412864 A CA 002412864A CA 2412864 A CA2412864 A CA 2412864A CA 2412864 A1 CA2412864 A1 CA 2412864A1
Authority
CA
Canada
Prior art keywords
beta
androgen
hydroxyestra
dien
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002412864A
Other languages
English (en)
Other versions
CA2412864C (fr
Inventor
Richard P. Blye
Hyun K. Kim
Carmie Kirk Acosta
Pemmaraju Narasimha Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/010293 external-priority patent/WO2001074839A2/fr
Application filed by Individual filed Critical Individual
Publication of CA2412864A1 publication Critical patent/CA2412864A1/fr
Priority claimed from PCT/US2002/009886 external-priority patent/WO2003045398A1/fr
Application granted granted Critical
Publication of CA2412864C publication Critical patent/CA2412864C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne des procédés d'utilisation de 7 alpha ,11ss-diméthyl-17ss-hydroxyestra-4,14-dièn-3-one (III), de 7 alpha -méthyl-17ss hydroxyestra-4,14-dièn-3-one, et des esters en position 17 de ces composés destinés à diverses thérapies hormonales, des formes de dosage orale et parentérale contenant ces composés actifs, ainsi que leurs procédés de préparation.
CA2412864A 2000-03-31 2002-03-29 Methodes de preparation et utilisation, et formulations pharmaceutiques renfermant 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one et leurs 17-esters Expired - Fee Related CA2412864C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19353000P 2000-03-31 2000-03-31
US60/193,530 2000-03-31
US19444000P 2000-04-04 2000-04-04
US60/194,440 2000-04-04
PCT/US2001/010293 WO2001074839A2 (fr) 2000-03-31 2001-03-30 Procedes de preparation et d'utilisation de7$g(a),11?-dimethyl-17?-hydroxy-4-estren-3-one 17?-$i(trans)-4-$i(n)-butylcyclohexane carboxylate et 7$g(a),11?-dimethyl-17?-hydroxyestr-4-en-3-one 17-undecanoate
WOPCT/US01/10293 2001-03-30
PCT/US2002/009886 WO2003045398A1 (fr) 2001-03-30 2002-03-29 Procedes de fabrication de formulations pharmaceutiques comprenant du 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one et des esters en position 17 de ce compose

Publications (2)

Publication Number Publication Date
CA2412864A1 true CA2412864A1 (fr) 2002-03-29
CA2412864C CA2412864C (fr) 2010-06-22

Family

ID=27359057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2412864A Expired - Fee Related CA2412864C (fr) 2000-03-31 2002-03-29 Methodes de preparation et utilisation, et formulations pharmaceutiques renfermant 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one et leurs 17-esters

Country Status (1)

Country Link
CA (1) CA2412864C (fr)

Also Published As

Publication number Publication date
CA2412864C (fr) 2010-06-22

Similar Documents

Publication Publication Date Title
AU692659B2 (en) Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors
JP3441459B2 (ja) ホルモン補充のための薬剤の調整方法
JP3002117B2 (ja) 生物起原のエストロゲン成分を含む避妊／ホルモン置換のための医薬
EP0424954B1 (fr) Composition pharmaceutique pour le traitement de l'ostéoporosis
WO1994023722A1 (fr) Activite de tamponnage de l'hydrocortisone
US6451779B1 (en) Composition and method for contraception and treatment of tumors of the mammary glands
EP1272196B1 (fr) Procedes de preparation des esters 4-n-butylcyclohexanoique et undecanoique de la (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one et leur utilisation pharmaceutique
JPS6245845B2 (fr)
HU211931A9 (en) Two-stage contraception system and method using an estrogen and a progestin
CA2470703A1 (fr) Produits pharmaceutiques oraux renfermant 17.beta.-estradiol-3-alcanoate inferieur, procede d'administration et de preparation associes
SE463074B (sv) Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasi
AU2001249661A1 (en) Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
SK282796B6 (sk) Testosterónový derivát, farmaceutický prostriedok s jeho obsahom, jeho použitie a súprava s jeho obsahom
US5478566A (en) Stimulation of cytokine production
CA2389025A1 (fr) Composition hormonale a base d'un progestatif et d'un oestrogene et son utilisation
US10351587B2 (en) Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate
Stevenson Optimising delivery systems for HRT
US4076811A (en) Novel agents and methods for treatment of climacteric disturbances
EP0479867B1 (fr) Preparations utiles comme contraceptifs chez l'homme
CA2412864A1 (fr) Methodes de preparation et utilisation, et formulations pharmaceutiques renfermant 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one et leurs 17-esters
Vermeulen Longacting steroid preparations
RU2002124602A (ru) Композиция для мужской контрацепции, включающая норэтистерон
US4794119A (en) Aqueous crystalline suspension of steroid glycoesters
WO1998056386A1 (fr) Medicament permettant de traiter le syndrome post-menopausique et l'osteoporose, de reduire la masse graisseuse et d'augmenter la masse du corps excluant la graisse
WO1992011855A1 (fr) Procedes et compositions destines a reduire les symptomes lies a la menopause

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220301

MKLA Lapsed

Effective date: 20200831